Keeping Patients at the Center of GA Therapy: Preserving Vision vs Restoring Vision

How should retina specialists reframe their approach to GA therapy? In the final episode of this New Retina Radio miniseries, moderator John Kitchens, MD joins experts Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH, to explore how to shift doctor mindsets from restoring vision to preserving it. The panel discusses challenges of counseling without clear imaging endpoints, the role of AI and microperimetry in demonstrating treatment value, and why some providers remain hesitant to adopt complement inhibitors. They also consider lessons from past therapies, tissue preservation as a meaningful endpoint, and how innovation may soon deliver more potent options.
This content is editorially independent, supported by Astellas Pharma.